New Delhi: The Indian Immunological Institute, a subsidiary of the National Dairy Development Board (NDDB), is working on new vaccines to treat lumpy skin disease and infectious bovine rhinotracheitis ...
Indian Immunologicals Limited (IIL) is a name that few might have heard of outside the vaccine industry. But the vaccine maker is expected to play a crucial role in Bharat Biotech's ambitious plan to ...
In a move that will boost the production capacity of indigenously developed Covid-19 vaccine Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of Covaxin drug substance ...
https://www.thehindubusinessline.com/economy/agri-business/iil-launches-new-insecticide-to-tackle-pests-in-paddy-sugarcane/article67063209.ece Copy Agrochemical firm ...
Insecticides (India) Ltd (IIL) has launched GRANUVIA, a next-generation, future-ready insecticide in India. A media statement said that GRANUVIA is recommended for application at 30-35 days after ...
International Industries Limited (IIL) is proud to announce the successful completion of the solarisation of two schools under The Citizens Foundation (TCF) network — the IIL Campus and the Chinoy ...
The decision on the long pending issue of equity dilution in agro chemical major Insecticides India Limited (IIL) is expected to be hammered out in the next three to four months, said IIL managing ...
IIL exports various human and animal vaccines to over 50 countries and currently employs around 1,300 people. Biologicals firm Indian Immunologicals Ltd (IIL) on Wednesday said it will invest Rs 75 ...
Hyderabad: Indian Immunologicals Limited (IIL) announced a partnership with the Central Institute of Freshwater Aquaculture (CIFA), Bhubaneswar, an Indian Council of Agricultural Research (ICAR) ...
IIL was set up in Hyderabad in 1982 to indigenously develop and produce vaccine for highly infectious and fatal Foot and Mouth Disease (FMD). Hyderabad: Indian Immunologicals Ltd (IIL), a subsidiary ...
Vaccine maker Indian Immunologicals (IIL) on Friday handed the first lot of Covaxin drug substance to Bharat Biotech. A development expected to pave the way for augmenting the indigenous COVID-19 ...